Evidence map›Paper›PMID 27983510›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2016

Comparison of Leishmania typing results obtained from 16 European clinical laboratories in 2014.

Gert Van der Auwera, Aldert Bart, Carmen Chicharro, Sofia Cortes, Leigh Davidsson, Trentina Di Muccio, Jean-Claude Dujardin, Ingrid Felger, Maria Grazia Paglia, Felix Grimm and 9 more

Open access · diamondAbstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Evaluation of Multi-Target Genotyping (ITS-Pathogens (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Molecular Typing ofPathogens (Basel, Switzerland) · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Imported leishmaniasis in Sweden 1993-2016.Epidemiology and infection · 2018
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 18 institutions in 12 countries.

Gert Van der AuweraBiomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Aldert BartAcademic Medical Center, Amsterdam, The Netherlands.
Carmen ChicharroInstituto de Salud Carlos III, Madrid, Spain.
Sofia CortesGlobal Health and Tropical Medicine, GHTM, Instituto de Higiene e Medicina Tropical, UNL, Lisbon, Portugal.
Leigh DavidssonThe Public Health Agency of Sweden, Stockholm, Sweden.
Trentina Di MuccioIstituto Superiore di Sanità, Rome, Italy.
Jean-Claude DujardinBiomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Ingrid FelgerSwiss Tropical and Public Health Institute, Basel, Switzerland.
Maria Grazia PagliaNational Institute for Infectious Diseases (INMI) Lazzaro Spallanzani, Rome, Italy.
Felix GrimmInstitute of Parasitology, University of Zürich, Zürich, Switzerland.
Gundel HarmsInstitute of Tropical Medicine and International Health, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Charles L JaffeHebrew University, Hadassah Medical Centre, Jerusalem, Israel.
Monika ManserUnited Kingdom National External Quality Assessment Service, London, United Kingdom.
Christophe RavelUniversity of Montpellier, Montpellier, France.
Florence Robert-GangneuxCentre Hospitalier Universitaire de Rennes, Rennes, France.
Jeroen RoelfsemaNational Institute for Public Health and the Environment, RIVM, Bilthoven, The Netherlands.
Seray TözEge University, Faculty of Medicine, Department of Parasitology, Izmir, Turkey.
Jaco J VerweijSt. Elisabeth Hospital, Tilburg, The Netherlands.
Peter L ChiodiniHospital for Tropical Diseases, London, United Kingdom.
Instituut voor Tropische Geneeskunde · BEAcademic Medical Center · NLCentre Hospitalier Universitaire de Rennes · FRCharité - Universitätsmedizin Berlin · DEEge University · TRElisabeth-TweeSteden Ziekenhuis · NLEscuela Nacional de Sanidad · ESHadassah Medical Center · ILHM Prison and Probation Service · GBHospital for Tropical Diseases · GBInstituto de Investigação Científica Tropical · PTIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITIstituto Superiore di Sanità · ITNational Institute for Public Health and the Environment · NLPublic Health Agency of Sweden · SEUniversité de Montpellier · FRUniversity of Basel · CHUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leishmaniasis is endemic in southern Europe, and in other European countries cases are diagnosed in travellers who have visited affected areas both within the continent and beyond. Prompt and accurate diagnosis poses a challenge in clinical practice in Europe. Different methods exist for identification of the infecting Leishmania species. Sixteen clinical laboratories in 10 European countries, plus Israel and Turkey, conducted a study to assess their genotyping performance. DNA from 21 promastigote cultures of 13 species was analysed blindly by the routinely used typing method. Five different molecular targets were used, which were analysed with PCR-based methods. Different levels of identification were achieved, and either the Leishmania subgenus, species complex, or actual species were reported. The overall error rate of strains placed in the wrong complex or species was 8.5%. Various reasons for incorrect typing were identified. The study shows there is considerable room for improvement and standardisation of Leishmania typing. The use of well validated standard operating procedures is recommended, covering testing, interpretation, and reporting guidelines. Application of the internal transcribed spacer 1 of the rDNA array should be restricted to Old World samples, while the heat-shock protein 70 gene and the mini-exon can be applied globally.

Indexed as

DNA, KinetoplastDNA, ProtozoanDNA, RibosomalEuropeGenotypeHSP70 Heat-Shock ProteinsHumansIsraelLaboratoriesLeishmaniaLeishmaniasisPolymerase Chain ReactionPolymorphism, Restriction Fragment LengthSensitivity and SpecificityTurkeyDNA, KinetoplastDNA, ProtozoanDNA, RibosomalHSP70 Heat-Shock Proteinshsp70kinetoplast DNAleishmaniasismini-exonrDNA ITS1Typing

Identifiers

PMID27983510
PMCPMC5291127
OpenAlexW2562858316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.